Article History
Received: 29 May 2024
Revised: 2 September 2024
Accepted: 20 September 2024
First Online: 26 September 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: None of the authors has any potential conflict of interest.
: The procedures performed including 10 kHz SCS trial and implantation of the IPG was part of the usual treatment plan for patients with drug-resistant neuropathic pain and was not part of a prospective study requiring Institutional Review Board approval.
: The participant has consented to the submission of the case report to the journal.